<!DOCTYPE  html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"/><title>rgpv syllabus - rgpv timetable Microsoft Word - III  industrial pharmacy _SY_</title><meta name="author" content="Admin"/><style type="text/css"> * {margin:0; padding:0; text-indent:0; }
 h1 { color: black; font-family:Calibri, sans-serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 15pt; }
 .s1 { color: black; font-family:Calibri, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11pt; }
 .h2, h2 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 14pt; }
 h3 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 12pt; }
 .p, p { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; margin:0pt; }
 .a, a { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 .s2 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 12pt; }
 h4 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 11pt; }
 .s3 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11pt; }
 .s4 { color: #00F; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 11pt; }
 .s5 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 14pt; }
 li {display: block; }
 #l1 {padding-left: 0pt;counter-reset: c1 1; }
 #l1> li>*:first-child:before {counter-increment: c1; content: counter(c1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l1> li:first-child>*:first-child:before {counter-increment: c1 0;  }
 li {display: block; }
 #l2 {padding-left: 0pt;counter-reset: d1 1; }
 #l2> li>*:first-child:before {counter-increment: d1; content: counter(d1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11pt; }
 #l2> li:first-child>*:first-child:before {counter-increment: d1 0;  }
 li {display: block; }
 #l3 {padding-left: 0pt;counter-reset: e1 1; }
 #l3> li>*:first-child:before {counter-increment: e1; content: counter(e1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11pt; }
 #l3> li:first-child>*:first-child:before {counter-increment: e1 0;  }
 li {display: block; }
 #l4 {padding-left: 0pt;counter-reset: f1 1; }
 #l4> li>*:first-child:before {counter-increment: f1; content: counter(f1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11pt; }
 #l4> li:first-child>*:first-child:before {counter-increment: f1 0;  }
 li {display: block; }
 #l5 {padding-left: 0pt;counter-reset: g1 3; }
 #l5> li>*:first-child:before {counter-increment: g1; content: counter(g1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11pt; }
 #l5> li:first-child>*:first-child:before {counter-increment: g1 0;  }
 li {display: block; }
 #l6 {padding-left: 0pt;counter-reset: h1 8; }
 #l6> li>*:first-child:before {counter-increment: h1; content: counter(h1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11pt; }
 #l6> li:first-child>*:first-child:before {counter-increment: h1 0;  }
</style><!-- Basic Meta Tags -->
<meta charset="utf-8" />
<meta http-equiv="X-UA-Compatible" content="IE=edge" />
<meta name="viewport" content="width=device-width,initial-scale=1" />

<!-- Page Title and Description -->
<meta name="description" content="Download and view the latest RGPV syllabus and timetable in PDF." />
<meta name="keywords" content="download, view, RGPV, syllabus, timetable, PDF" />

<!-- Robots Meta Tag -->
<meta name="robots" content="index, follow" />
<link rel="sitemap" href="/sitemap.xml" />

<!-- Twitter Meta Tags -->
<meta name="twitter:card" content="summary_large_image" />
<meta name="twitter:title" content="RGPV Syllabus and Timetable" />
<meta name="twitter:description" content="Download and view the latest RGPV syllabus and timetable in PDF." />

<!-- Open Graph Meta Tags -->
<meta property="og:locale" content="en_IN" />
<meta property="og:type" content="website" />
<meta property="og:site_name" content="RGPV Syllabus and Timetable" />
<meta property="og:title" content="RGPV Syllabus and Timetable" />
<meta property="og:description" content="Download and view the latest RGPV syllabus and timetable in PDF." />

<!-- Other Tags -->
<link rel="prefetch" />
<meta name="audience" content="all" />
<meta name="rating" content="general" />
<meta name="generator" content="site" />
<meta name="google" content="translate" />
<meta name="theme-color" content="#4DBA87" />
<meta name="geo.placename" content="India" />
<meta name="revisit-after" content="1 days" />
<meta property="fb:admins" content="100012765211323" />
<meta name="apple-mobile-web-app-capable" content="no" />

<!-- Apple Touch Icon -->
<meta name="apple-mobile-web-app-title" content="www.rgpv-syllabus-timetable.in" />
<meta name="apple-mobile-web-app-status-bar-style" content="default" />
<link rel="apple-touch-icon" href="/img/icons/apple-touch-icon-152x152.png" />

<!-- Favicon and Icons -->
<link rel="mask-icon" href="/img/icons/safari-pinned-tab.svg" color="#4DBA87" />
<link rel="icon" type="image/png" sizes="32x32" href="/img/icons/favicon-32x32.png" />
<link rel="icon" type="image/png" sizes="16x16" href="/img/icons/favicon-16x16.png" />
<meta name="msapplication-TileImage" content="/img/icons/msapplication-icon-144x144.png" />

<!-- Search Engine Tags -->
<meta name="search engines" content="Aeiwi, Alexa, AllTheWeb, AltaVista, AOL Netfind, Anzwers, Canada, DirectHit, EuroSeek, Excite, Overture, Go, Google, HotBot, InfoMak, Kanoodle, Lycos, MasterSite, National Directory, Northern Light, SearchIt, SimpleSearch, WebsMostLinked, WebTop, What-U-Seek, AOL, Yahoo, WebCrawler, Infoseek, Excite, Magellan, LookSmart, CNET, Googlebot" />

<!-- Pingback and OpenID -->
<link rel="pingback" href="https://www.rgpv-syllabus-timetable.in/" />
<link rel="openid.delegate" href="https://www.rgpv-syllabus-timetable.in/" />

<!-- Content Type -->
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
<body><div style="display:flex;justify-content:flex-end;"><a href="#" target="_blank" download="" id="pdf-download-link"><button type="button" style="cursor:pointer;-webkit-appearance:button;color:#fff;background-color:#007bff;border-color:#007bff;display:inline-block;font-weight:400;text-align:center;white-space:nowrap;vertical-align:middle;-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;border:1px solid transparent;padding:0.375rem 0.75rem;font-size:1rem;line-height:1.5;border-radius:0.25rem;transition:color .15s ease-in-out,background-color .15s ease-in-out,border-color .15s ease-in-out,box-shadow .15s ease-in-out;text-transform:none;overflow:visible;margin:0;font-family:inherit;" download>Download PDF</button></a></div><script>const a=(window.location.pathname).split("/");const filename="" + a[a.length-1] + ".pdf";document.getElementById("pdf-download-link").href=filename;</script><h1 style="padding-top: 4pt;padding-left: 41pt;text-indent: 0pt;text-align: left;">MPY301-IP <span class="s1">-</span><span class="h2">INTELLECTUAL PROPERTY RIGHTS</span></h1><h3 style="padding-top: 12pt;padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Unit I</h3><p style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Intellectual property: Trade related intellectual property rights: Patent, Industrial Designs, Trade Mark, Copyright, Geographical Indication, Layout Designs of Integrated Circuit, Protection of Undisclosed Information/Trade Secrets. Types of patent applications.</p><h3 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Unit II</h3><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 2pt;text-align: justify;">Patents Act (Indian Legislation): Inventions, Inventions not patentable, forms of application, Information  and  undertaking  regarding  foreign  applications,  Provisional  and  complete specifications, Contents of specifications, Priority dates of claims of a complete specification, Publication and examination of application, withdrawal of an application. Grant of patent: Grant and sealing of patent, Opposition to grant of patent, post grant opposition, Amendment of patent granted to deceased applicant, Important dates of patent, Rights of patentee, Rights of co-owners of patents, Term of patent,  Patents of addition, Amendment of application and specification, restoration of lapsed patents, surrender and revocation of patents, Register of patents, use of inventions for purposes of government and acquisition of inventions by central government, Suits concerning infringement of patents. Offences and penalties. Forms and fees structure used in filing of patent.</p><h3 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Unit III</h3><p style="padding-top: 6pt;padding-left: 5pt;text-indent: 0pt;text-align: justify;">Patent Officials: Controller Generally; Power of controller, time frame, acceptance. Exclusive marketing rights: Application for grant of exclusive rights, Grant of exclusive rights, Compulsory licenses, Suits relating to infringements, Opposition to grant of patent, Refusal of patent without opposition, Anticipations, provisions for secrecy of certain inventions, Patent agents:  Register of patent agents, Qualifications for registration as patent agents, Rights of patent agents, Subscription and verification of certain documents by patent agents, Restrictions on practice as patent agents, Removal from register of patent agents and restoration.</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Unit IV</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">International Arrangements: Notification as to convention countries, Notification as to countries not providing for reciprocity, Patent Cooperation treaty, Overview of PCT process, Convention applications, Special provisions relating  to  convention applications, Multiple priorities, Supplementary provisions as to convention applications, Other provisions of Act to apply to convention applications</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Unit V</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 2pt;line-height: 114%;text-align: justify;">Patent Drafting: Case study for proper drafting of complete specification relating to: title of invention, Field of invention, Background of invention with regard to the drawback associated with known art, Object of invention, Statement of invention, summary of invention, brief description of the accompanying drawing, detailed description of the invention with reference to drawing/examples, claim(s), Abstract.</p><h3 style="padding-left: 8pt;text-indent: 0pt;line-height: 14pt;text-align: justify;">Books and References Recommended<span class="p">:</span></h3><ol id="l1"><li data-list-text="1."><p style="padding-left: 17pt;text-indent: -12pt;line-height: 14pt;text-align: left;">The Gazettes of India. The Patent Act 1970 and its Latest amendments.</p></li><li data-list-text="2."><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">J. L. Rogers, The complete patent book: Everything you need to know to obtain your patent. Sphinx Publishing.</p></li><li data-list-text="3."><p style="padding-left: 17pt;text-indent: -12pt;text-align: left;"><a href="http://www.ep.espace.net/" class="a" target="_blank">www.uspto.gov.in 4. </a><a href="http://www.ep.espace.net/" target="_blank">www.ep.espace.net</a></p></li></ol><h2 style="padding-top: 4pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">MPY-302-IP    <span class="s2">INTERNATIONAL    BUSINESS    MANAGEMENT    OF PHARMACEUTICAL PRODUCTS</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Unit I</h3><p style="padding-left: 5pt;text-indent: 2pt;text-align: justify;">International business - meaning and modes of International business; Globalization – concepts, characteristics and drivers; International business environment – cultural, economic, political and legal environment;</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Unit II</h3><p style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">World Trade Organizations (WTO) – structure and overview of agreements; Regional economic groupings – meaning, levels and implications for International business; Foreign Direct Investments (FDI’s) – concepts, types, motives, impact of FDI, Foreign Direct Investment in India</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Unit III</h3><p style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Multinational Enterprises (MNEs) – features, types, factors affecting MNEs; Foreign market entry strategies and strategic alliances – basic entry decisions, entry modes selection, reasons and process of strategic alliance management.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Unit IV</h3><p style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Export-Import policy in India – salient features; International commercial terms (Incoterms); Import- Export documentation - Bill of Exchange, Marine Insurance policy, Invoices and other documents; Transport documents - Bill of lading, Airway Bill, Multimodal transport documents; Letter of Credit – meaning, types of letter of credit; Financing exports - preshipment credit, post- shipment finance; Financing imports; Export credit Insurance – standard and specific policies, guarantees.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Unit V</h3><p style="padding-left: 5pt;text-indent: 2pt;text-align: justify;">The Indian Contract Act, 1872 – meaning and essentials of contract ; Offer and Acceptance; Capacity of the parties; Consideration; Free consent; Legality of object; Performance; Discharge and remedies for breach of contract. Sale of Goods Act, 1930 – relevant provisions. Companies Act, 1956 – meaning, characteristics and types of companies; Formation of company; Meaning and  contents  of Memorandum  of  Association  and  Articles  of  Association;  Company management and managerial remuneration; Company meetings and proceedings.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Books and References Recommended<span class="s3">:</span></h4><ol id="l2"><li data-list-text="1."><p class="s3" style="padding-top: 6pt;padding-left: 16pt;text-indent: -11pt;text-align: left;">Sundram and Black: International business environment, Prentice Hall of India.</p></li><li data-list-text="2."><p class="s3" style="padding-left: 16pt;text-indent: -11pt;line-height: 13pt;text-align: left;">Charles WL Hill: International business, Tata Mc Graw Hill, New Delhi.</p></li><li data-list-text="3."><p class="s3" style="padding-left: 16pt;text-indent: -11pt;line-height: 13pt;text-align: left;">Arun Kumar Jain: Competing in the Global market place, Tata Mc Graw Hill New Delhi.</p></li><li data-list-text="4."><p class="s3" style="padding-left: 16pt;text-indent: -11pt;text-align: left;">Francis Cherunilam; International business, Prentice Hall of India.</p></li><li data-list-text="5."><p class="s3" style="padding-left: 16pt;text-indent: -11pt;text-align: left;">Sunil Gupta: International Marketing, Kalyani Publishers New Delhi.</p></li></ol><h3 style="padding-top: 4pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">MPY-303-IP: PHARMACEUTICAL DOCUMENTATION &amp; REGULATORY AFFAIRS</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Unit I</h3><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 114%;text-align: justify;">Pharmaceutical  manufacturing  documentation  (PMD)  –  Guidelines  for  designing  and implementation  of  PMD  programme.  Advantages  and  applications  of  pharmaceutical documentation, Regulatory requirement of pharmaceutical documentation: Standard practices in preparation, issue, use and archival of documents, records, reports and disposal of documents.</p><h3 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Unit II</h3><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 114%;text-align: justify;">Pharmaceutical documents for production operations: Standard formats, contents, designing and preparation of- Batch Processing Record/Batch Manufacturing Record (BPR/BMR), Batch Packaging records, Batch testing records, Site Master File, Standard Operating Procedure (SOP), Certificate of Analysis (COA), quality specification, Material Safety Data Sheet (MSDS).</p><h3 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Unit III</h3><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 114%;text-align: justify;">Pharmaceutical documents for R&amp;D and quality operations: Standard formats, contents, designing and preparation of- Master Formula Record (MFR), Product Development Record (PDR), Drug Master File (DMF), Method of Analysis/Standard Testing Procedure (MOA/STP), Validation master plan, Validation protocols, validation reports, inspection &amp; audit reports.</p><h3 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Unit IV</h3><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 114%;text-align: justify;">Standard formats, contents and preparation of SOP and validation documents of various Non- sterile  processes,  i.e.,  Mixing,  granulation,  drying,  compression,  coating,  blending, homogenization; Sterile processes, i.e., sterilization, depyrogenation, Cleaning/washing, filling, lyophilization, filtration processes. SOP and validation documents of packaging operations.</p><h3 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Unit V</h3><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 114%;text-align: justify;">ICH  guidelines  for  pharmaceutical  quality  aspects:  Common  Technical  Documents (CTD),Quality of Biotechnological Products Q5A - Q5E, Specifications Q6A- Q6B, Impurities Q3A Q3D , Stability Q1A - Q1F , Pharmacopoeias Q4 - Q4B , Quality Risk Management Q9, Pharmaceutical Quality System Q10 , Electronic documentation and electronic filing .</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Recommended Books</h4><ol id="l3"><li data-list-text="1."><p class="s3" style="padding-top: 1pt;padding-left: 16pt;text-indent: -11pt;text-align: left;">The Pharmaceutical Regulatory Process, 2nd ed. – Ira R. Berry, Robert P. Martin</p></li><li data-list-text="2."><p class="s3" style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 115%;text-align: left;">Medical Product Regulatory Affairs: Pharmaceutical , Diagnostics, Medical Devices –John J. Tobin and Gary Walsh</p></li><li data-list-text="3."><p class="s3" style="padding-left: 5pt;text-indent: 0pt;line-height: 115%;text-align: left;">FDA Regulatory Affairs: A Guide for Prescription Drugs, Medical Devices and Biologics, 2nd ed. – Douglas J. Pisano and David S. Mantus</p></li><li data-list-text="4."><p class="s3" style="padding-left: 5pt;text-indent: 0pt;line-height: 115%;text-align: left;">Good Drug Regulatory Practices: a Regulatory Affairs Quality Manual (Good Drug Development Series) – Helene I. Dumitriu</p></li><li data-list-text="5."><p style="padding-left: 16pt;text-indent: -11pt;line-height: 13pt;text-align: left;"><a href="http://www.ich.org/" style=" color: black; font-family:&quot;Times New Roman&quot;, serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11pt;" target="_blank">ICH guidelines- </a><a href="http://www.ich.org/" class="s4" target="_blank">www.ich.org</a></p></li></ol><h3 style="padding-top: 4pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">MPY 304 IP: <span class="s5">NOVEL DRUG DELIVERY SYSTEMS</span></h3><h3 style="padding-top: 12pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Unit I</h3><h3 style="padding-top: 1pt;padding-left: 5pt;text-indent: 2pt;line-height: 114%;text-align: justify;">Controlled Drug Delivery Systems<span class="p">- Concepts and Rationale,  Classification of controlled release systems , Carriers for CDDS , Design and evaluation , Release Kinetics</span></h3><h3 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Unit II</h3><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 2pt;line-height: 114%;text-align: justify;">General Considerations, Methods of Preparation, Characterization   and Applications of following drug Delivery Systems: Microspheres, Liposomes, Niosomes, Resealed Erythrocytes, Nanoparticles, Solid Lipid Nanoparticles,   Dendrimers , Multiple emulsions Submicron emulsion.</p><h3 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Unit III</h3><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 115%;text-align: justify;">Transdermal Drug Delivery System (TDDS)  : General considerations , Basic Components, Different approaches, Methods of enhancements of percutaneous absorption , Evaluations and applications of TDDS</p><h3 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Unit IV</h3><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 114%;text-align: justify;">Implants and Inserts : General considerations, Mechanism of drug release, Various approaches and Devices , Applications</p><h3 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Unit V</h3><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 114%;text-align: justify;">Osmotically Regulated Systems i General considerations , Classifications and development of Osmotic Pumps , Applications</p><h3 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Unit VI</h3><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;text-align: justify;">Colon – Specific drug delivery, General considerations, Various approaches and applications</p><h3 style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Unit VII</h3><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;text-align: justify;">An overview of oral controlled drug delivery</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 5pt;text-indent: 0pt;line-height: 12pt;text-align: justify;">Book and References Recommended</h4><ol id="l4"><li data-list-text="1."><p class="s3" style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Jain, N. K., “Controlled &amp; Novel drug delivery”, CBS Publishers &amp; distributors, New Delhi. 2. Jain, N. K., “Advances in Controlled &amp; Novel drug delivery”, CBS Publishers &amp; distributors, New Delhi</p></li></ol><ol id="l5"><li data-list-text="3."><p class="s3" style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Vyas , S. P. and Khar, R. K. “Controlled drug delivery – Concepts &amp; Advances”, Vallabh Prakashn, Delhi</p></li><li data-list-text="4."><p class="s3" style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Vyas, S. P. and Khar, R. K, “Targeted &amp; Controlled drug delivery Novel Carrier Systems”, CBS Publishers, New Delhi.</p></li><li data-list-text="5."><p class="s3" style="padding-left: 16pt;text-indent: -11pt;line-height: 13pt;text-align: justify;">Mathiowitz, E., “Encyclopedia of Controlled drug delivery” Vol - 1 &amp; II, John Wiley &amp; Sons, Canada</p></li><li data-list-text="6."><p class="s3" style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Swarbick , J. and Boyln, J ., “Encyclopedia of pharmaceutical technology” Vol. 1- III, Marcel Dekker , Inc ., New York. 7. Jones, D. A., “Transdeermal &amp; related drug delivery system”, Marcel Dekker , Inc ., NY.</p></li></ol><ol id="l6"><li data-list-text="8."><p class="s3" style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Robinson, J. R. and Lee,. H., “Controlled drug delivery fundamentals &amp; applications” Marcel Dekker , Inc., New York.</p></li><li data-list-text="9."><p class="s3" style="padding-left: 16pt;text-indent: -11pt;line-height: 13pt;text-align: left;">Chein , Y. W. , “Transdermal controlled systemic medications” Marcel Dekker, Inc., New York .</p></li><li data-list-text="10."><p class="s3" style="padding-left: 24pt;text-indent: -19pt;line-height: 13pt;text-align: left;">Hillery , A . and Llyod, A. W., “Drug delivery &amp; Targetting”, Taylor &amp; Francis, London</p></li><li data-list-text="11."><p class="s3" style="padding-left: 27pt;text-indent: -22pt;text-align: left;">Deasy, P. B., “Microencapsulations &amp; related drug processes” Marcel Dekker, Inc., New York.</p></li></ol></body></html>
